Sen. Burr Introduces Clean Reauthorization of FDA User Fee Programs
July 15, 2022
July 15, 2022
WASHINGTON, July 15 -- Sen. Richard Burr, R-North Carolina, ranking member of the Senate Health, Education, Labor and Pensions Committee, issued the following news release:
Senator Richard Burr (R-NC), Ranking Member of the Senate Committee onHealth, Education, Labor and Pensions (HELP), introduced the Food and Drug Administration Simple Reauthorization Act, that would reauthorize the Food and Drug Administration's (FDA) prescription drug, generic drug, biosimilar, and medical . . .
Senator Richard Burr (R-NC), Ranking Member of the Senate Committee onHealth, Education, Labor and Pensions (HELP), introduced the Food and Drug Administration Simple Reauthorization Act, that would reauthorize the Food and Drug Administration's (FDA) prescription drug, generic drug, biosimilar, and medical . . .